Sarcoidosis — all decisions

The appeal for an earlier effective date was denied, but the Veteran's individual unemployability (TDIU) and eligibility for Dependents Educational Assistance were granted from October 30, 2019.

The Board granted service connection for sarcoidosis on a direct basis, effective August 10, 2022.

The Board granted a 30 percent disability rating for sarcoidosis from February 28, 2023, and denied higher ratings for lumbar spine degenerative arthritis, left lower extremity radiculopathy, and major depressive disorder with generalized anxiety disorder.

The Board remands the claims for service connection for cause of death and dependency and indemnity compensation (DIC) benefits due to a pre-decisional duty to assist error regarding the appeal for service connection for cause of death.

The Board remands the claim for service connection for sarcoidosis to correct a pre-decisional duty-to-assist error, requiring a VA examination and opinion regarding the etiology of the condition.

The Board remands the Veteran's claim for service connection for sarcoidosis to afford the Veteran an examination with an examiner who can provide a more thorough opinion on the etiology of his condition, considering all potential exposures during his military service.

The Board remands the claims for service connection for the Veteran's cause of death and entitlement to Dependency and Indemnity Compensation under 38 USC § 1151 due to inadequate medical opinions.

The Board denied service connection for chronic fatigue syndrome, sinusitis, and sleep apnea but granted service connection for bilateral ankle strain and bilateral knee strain. The claims for increased ratings were also denied.

The Board is remanding the matter for another examination to address evidence indicating the use of Fluticasone and whether it required corticosteroid use to control the Veteran's sarcoidosis condition.

The Board remands the claims for service connection for sarcoidosis and pulmonary hypertension due to inadequate development of in-service toxic exposure risk activities.

The Board denied an initial compensable rating for sarcoidosis with interstitial lung disease and remanded the issue of a rating for extra-pulmonary involvement of sarcoidosis.

The Board remands the claims for an increased rating for sarcoidosis with OSA and an initial compensable rating for chronic bronchitis with COPD to obtain additional evidence.

The Board denied service connection for an eye disability, diagnosed as cataracts and dry eye syndrome, and a respiratory disability, other than sarcoidosis.

The Board granted a 10 percent disability evaluation for the Veteran's sarcoidosis based on pulmonary function test results.